Zhang Wenjie, Yin Bohua, Li Xinning, Lei Jiaxin, Xiao Yanying, Wang Yaping, Zou Dingquan
Department of Pain Management, Second Xiangya Hospital, Central South University, Changsha 410011.
Clinical Research Center for Pain Medicine in Hunan Province, Changsha 410011.
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2025 Jun 28;50(6):995-1001. doi: 10.11817/j.issn.1672-7347.2025.250049.
Managing patients with refractory head and neck cancer pain is one of the more challenging issues in clinical practice, and traditional intrathecal drug delivery also fails to provide adequate analgesia. There are currently no comprehensive and effective treatment methods. This study aims to observe the efficacy and safety of treating intractable head and neck cancer pain with morphine pump via lumbar approach to the prepontine cistern.
A total of 18 patients with intractable head and neck cancer pain treated with prepontine cistern morphine pumps were selected from the Department of Pain Management, Second Xiangya Hospital, Central South University between September 2019 and July 2023. Statistical analysis was performed on patients' preoperative and postoperative (1 week, 1 month, and 2 months after surgery), Numerical Rating Scale (NRS) scores, Self-Rating Depression Scale (SDS) scores, daily oral morphine consumption, the number of daily breakthrough pain episodes, and postoperative daily intrathecal morphine dosage.
The NRS scores, SDS scores, daily oral morphine consumption, and the number of daily breakthrough pain episodes of patients at each time point after surgery were significantly lower than before surgery (all <0.05). With the gradual increase in the dosage of intrathecal morphine, the daily oral morphine consumption of patients at each postoperative time point was significantly reduced compared to preoperative levels (all <0.05). The complications related to the operation were mild, including nausea in 5 cases (31.3%), headache in 2 cases (12.5%); hypotension, urine retention, hypersomnia and constipation in 1 case (6.3% each), and no serious adverse events occurred. All improved and were discharged after symptomatic treatment.
The implantation of prepontine cistern morphine pump effectively controls intractable head and neck cancer pain, demonstrating characteristics of minimal invasiveness, mild side effects, and low medication dosage under the premise of standardized procedures.
难治性头颈癌疼痛患者的管理是临床实践中较具挑战性的问题之一,传统的鞘内药物输注也无法提供充分的镇痛效果。目前尚无全面有效的治疗方法。本研究旨在观察经腰段入路至脑桥前池使用吗啡泵治疗顽固性头颈癌疼痛的疗效和安全性。
选取2019年9月至2023年7月期间在中南大学湘雅二医院疼痛科接受脑桥前池吗啡泵治疗的18例顽固性头颈癌疼痛患者。对患者术前及术后(术后1周、1个月和2个月)的数字评分量表(NRS)评分、自评抑郁量表(SDS)评分、每日口服吗啡用量、每日爆发性疼痛发作次数及术后每日鞘内吗啡用量进行统计学分析。
患者术后各时间点的NRS评分、SDS评分、每日口服吗啡用量及每日爆发性疼痛发作次数均显著低于术前(均P<0.05)。随着鞘内吗啡用量的逐渐增加,患者术后各时间点的每日口服吗啡用量与术前相比均显著降低(均P<0.05)。与手术相关的并发症较轻,包括恶心5例(31.3%)、头痛2例(12.5%);低血压、尿潴留、嗜睡及便秘各1例(各6.3%),未发生严重不良事件。经对症处理后均好转出院。
脑桥前池吗啡泵植入术能有效控制顽固性头颈癌疼痛,在规范操作的前提下,具有微创、副作用轻、用药量低的特点。